Press Releases

Press Releases

Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Bristol-Myers Squibb (NYSE:BMY) has selected the Medidata Clinical Cloud® to help manage, monitor and analyze its clinical trials. Medidata’s cutting-edge technology platform will support Bristol-Myers Squibb’s research capabilities in immuno-oncology, oncology, immunoscience, virology,…

Press Releases

Bioclinica, Inc., a specialty clinical trials technology and services provider, today announced the selection of ArisGlobal's Safety Cloud as the preferred safety platform for its pharmacovigilance services. Under this partnership, Bioclinica becomes the preferred partner for ArisGlobal in business process consulting and change management as sponsors implement or upgrade ARISg. …

Press Releases

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that its collaborators from the University of British Columbia's Vancouver Prostate Center presented results of new research related to the anti-cancer mechanism of its lead anti-cancer product candidate, VAL-083 (dianhydrogalactitol). Abstract #2985:…

Press Releases

“The launch of a new business unit tremendously expands our capabilities in the analysis, engineering and implementation of continuous pharmaceutical manufacturing,” states Daisy Rivera-Muzzio, RPh, MBA, President and Co-founder of Acumen BioPharma, LLC. “The new unit, Integra™ Continuous Manufacturing Systems, will be headed by Fernando Muzzio, PhD, a renowned leader…

Press Releases

AMO Pharma Limited, a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options, announced today the appointment of Joseph Horrigan as chief medical officer.   Dr. Horrigan comes to AMO Pharma with more than two decades of experience in the pharmaceutical industry and as a…

Press Releases

Elorac, Inc. announced today that it has acquired Gideon Pharmaceuticals, Inc. in an all-stock transaction. Gideon Pharmaceuticals’ leading development-stage pharmaceutical products employ its patented Heprotect™ technology, which significantly reduces the hepatotoxicity of hepatocellular toxic agents without interfering with their bioactivity. Among the drugs being developed by Gideon are Heprotect versions…

Press Releases

Gilead Sciences, Inc. today announced data supporting the development of three investigational agents for the treatment of nonalcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC). The data were presented in oral and poster sessions at The International Liver CongressTM 2016 in Barcelona, Spain. NASH is a serious liver disease resulting…

Friday, Apr 15, 2016
Press Releases

WuXi AppTec, a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, today announced that it has acquired Crelux GmbH, a leading structure based drug discovery provider based in Munich, Germany. The addition of Crelux provides augmented scientific depth and complements existing capabilities…

Press Releases

Catalent, Inc., the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, today announced that it will release financial results for the third quarter of fiscal year 2016 ended March 31, 2016, after the market close on Wednesday, May 4, 2016. The…

BioPharmX to Report Fourth Quarter and Full Year Financial Results on April 26, 2016

BioPharmX Corporation, a specialty pharmaceutical company focusing on dermatology and women's health, today announced that it will release its financial results for the fiscal fourth quarter and full year ended January 31, 2016 after the close of trading on Tuesday, April 26, 2016. The company's management team will host a…